Innovent Biologics has entered into a landmark strategic partnership with pharmaceutical giant Pfizer, a move that sent the biotech firm’s stock surging by 10%. The collaboration centers on the research, development, and commercialization of 12 early-stage and de novo cancer treatments, with a specific focus on the rapidly evolving field of antibody-drug conjugates. This deal […]